List of insiders holdings for HALOZYME THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
KIRK RANDAL J 10% Owner | 2019-11-05 16:53:10 | 7,046,385 0 | 7,046,385 | Form 13D |
Frost Gregory Ian CEO, President | 2013-12-11 19:33:00 | 3,676,911 0 | 3,676,911 | Form 4 |
LECHNER IRA M Director | 2004-03-19 14:12:33 | 100,000 1,052,329 | 1,152,329 | Form 3 |
MERCALDO EDWARD L Director | 2004-03-19 14:13:19 | 126,944 692,994 | 819,938 | Form 3 |
Torley Helen PRESIDENT AND CEO | 2024-10-09 17:39:44 | 686,744 0 | 686,744 | Form 4 |
Wilson Mark S Vice President | 2005-02-11 15:46:01 | 544,240 0 | 544,240 | Form 3/A |
Rynard Carolyn Vice President | 2005-02-11 15:55:34 | 494,240 0 | 494,240 | Form 3/A |
RAMSAY DAVID A VP and Chief Financial Officer | 2015-02-06 19:52:31 | 458,582 0 | 458,582 | Form 4 |
FALBERG KATHRYN E Director | 2016-05-06 16:47:56 | 358,253 0 | 358,253 | Form 4 |
Engler Robert Director | 2014-08-18 16:59:47 | 273,176 0 | 273,176 | Form 4 |
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-10-16 18:53:48 | 243,324 0 | 243,324 | Form 4 |
MATSUI CONNIE Director | 2024-04-29 18:05:41 | 202,309 0 | 202,309 | Form 4 |
Leff Jonathan A VP, Chief Medical Officer | 2009-08-07 20:20:32 | 200,000 0 | 200,000 | Form 4 |
Armour Alison A. SVP, Research & Development | 2019-06-04 16:44:05 | 195,278 0 | 195,278 | Form 4 |
PATTON JOHN STUART Director | 2014-08-21 17:07:42 | 179,876 0 | 179,876 | Form 4 |
Kelley Kenneth J Director | 2021-04-14 16:19:55 | 179,833 0 | 179,833 | Form 4 |
Yocum Richard C VP-Clinical Development | 2008-02-08 17:50:38 | 150,943 0 | 150,943 | Form 4 |
Stelzer Laurie SVP, Chief Financial Officer | 2020-02-24 20:03:57 | 127,559 10,000 | 137,559 | Form 4 |
Hooper Matthew Vice Pres & General Counsel | 2007-11-13 16:35:47 | 125,000 0 | 125,000 | Form 4 |
Lim Jonathan E Chief Executive Officer | 2010-02-08 17:06:43 | 120,000 0 | 120,000 | Form 4 |
Countouriotis Athena SVP and Chief Medical Officer | 2017-02-24 16:06:20 | 118,493 0 | 118,493 | Form 4 |
Gergen Mark J SVP, Chief Operating Officer | 2017-02-24 16:05:43 | 118,493 0 | 118,493 | Form 4 |
GUSTAFSON KURT A Vice President and CFO | 2013-02-06 18:58:12 | 99,200 0 | 99,200 | Form 4 |
Shaffer James P VP & Chief Commercial Officer | 2014-02-10 17:57:12 | 81,500 0 | 81,500 | Form 4 |
LIU JEAN I VP & General Counsel | 2014-02-10 17:55:14 | 81,500 0 | 81,500 | Form 4 |
BIZZARI JEAN-PIERRE Director | 2023-05-09 18:09:24 | 78,186 0 | 78,186 | Form 4 |
Hickey Benjamin SVP, Chief Commerical Officer | 2019-10-01 19:10:12 | 73,873 0 | 73,873 | Form 4 |
Posard Matthew L. Director | 2024-08-14 16:57:27 | 69,874 0 | 69,874 | Form 4 |
LEONHARDT HARRY J SVP, GC | 2019-04-15 16:08:01 | 66,373 0 | 66,373 | Form 4 |
Henderson Jeffrey William Director | 2024-04-29 17:56:55 | 62,415 0 | 62,415 | Form 4 |
Connaughton Bernadette Director | 2024-04-29 17:51:24 | 55,591 0 | 55,591 | Form 4 |
Thornton Steven T Director | 2008-05-09 18:26:18 | 50,000 0 | 50,000 | Form 4 |
Sun Elaine D SVP, Chief Financial Officer | 2021-04-01 19:43:33 | 44,618 0 | 44,618 | Form 4 |
Chondros Dimitrios SVP, Chief Medical Officer | 2019-08-05 20:11:39 | 38,584 0 | 38,584 | Form 4 |
Miyashita Akiko Moni Director | 2024-04-29 18:08:11 | 29,576 0 | 29,576 | Form 4 |
LITTLE ROBERT J VP, Chief Commercial Officer | 2010-02-08 17:52:41 | 28,000 0 | 28,000 | Form 4 |
Matsuda Masaru SVP, General Counsel | 2021-09-07 17:42:24 | 26,932 0 | 26,932 | Form 4 |
Duncan Barbara Gayle Director | 2024-04-29 17:54:20 | 24,558 0 | 24,558 | Form 4 |
DAY MELLISSA former officer, director Director | 2004-03-12 13:24:02 | 22,374 0 | 22,374 | Form 4 |
Daly James M Director | 2023-08-15 16:04:28 | 20,503 0 | 20,503 | Form 4 |
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2024-06-14 16:17:33 | 20,137 0 | 20,137 | Form 4 |
Fallon William J VP, Manufacturing & Operations | 2011-05-11 19:44:04 | 19,000 0 | 19,000 | Form 4 |
LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2024-07-23 16:37:10 | 15,480 0 | 15,480 | Form 4 |
Krishnan Mahesh Director | 2024-04-29 18:01:02 | 15,305 0 | 15,305 | Form 4 |
KEELER MITCH former off., dir., 10% owner | 2004-03-12 13:52:53 | 15,000 0 | 15,000 | Form 13G |
Shepard H. Michael VP, Chief Scientific Officer | 2013-09-11 18:12:07 | 13,198 0 | 13,198 | Form 4 |
Kennard Don A Vice President, Regulatory Aff | 2007-05-23 16:16:59 | 0 0 | 0 | Form 4 |